胰腺癌立体定向体部放疗:分次间解剖变化对危及器官剂量的影响
研究纳入35例接受40 Gy/5次SBRT的胰腺癌患者,于前三分数次行CT-on-rails扫描并手动勾画胃、十二指肠、肠管为胃肠道器官,比较分次CT与计划CT的剂量体积直方图参数。结果显示分次间解剖变化使胃肠道器官V35、D2、D5、D10及Dmax中位数升高,所有参数在胃肠道器官中及所有关键结构的V35在Wilcoxon检验中均有统计学显著升高。
要点
- 35例胰腺癌患者接受40 Gy/5次SBRT,前三分数次行CT-on-rails扫描并基于基准点配准比较剂量。
- 分次CT较计划CT,胃肠道器官V35、D2、D5、D10和Dmax中位数分别升高1.0、4.4%、2.3%、3.3%和12.0%。
- 胃肠道器官所有剂量参数及所有关键结构的V35中位数升高在Wilcoxon检验中有统计学显著性。
核心结论
- 分次间解剖变化使胰腺癌SBRT中危及器官剂量升高,每日使用集成CT/CyberKnife成像可能有助于实施降低危及器官过度照射风险的策略。
研究设计与样本
- 研究纳入35例接受SBRT(40 Gy/5次)的胰腺癌患者,使用集成CT-on-rails系统于前三分数次行治疗体位CT扫描。
- 手动勾画胃、十二指肠、肠管并拼接为单一结构(胃肠道器官,GIO),基于基准点将分次CT与计划CT配准以叠加计划剂量分布。
- 比较计划DVH参数与分次CT计算的危及器官参数。
主要发现
- 与治疗计划相比,分次CT中胃肠道器官V35、D2、D5、D10和Dmax中位数分别升高1.0(IQR:0.2-2.6)、4.4%(IQR:0.4-10.8)、2.3%(IQR:0.2-7.5)、3.3%(IQR:-0.4至7.1)和12.0%(IQR:5.0-18.9)。
- 胃肠道器官所有参数及所有关键结构的V35中位数升高在Wilcoxon检验中有统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Interfraction shape and position variations of organs at risk (OARs) may increase uncertainty in dose delivery during stereotactic body radiotherapy (SBRT), potentially leading to overirradiation or concessions in planned tumor dose and/or coverage to prevent clinical constraints violation. The aim of our study was to quantitatively analyze the impact of anatomical interfraction variations on dose to OARs in pancreatic cancer (PC) treated by SBRT using a CyberKnife with integrated CT-on-rails. MATERIALS AND METHODS: Thirty-five PC patients treated with SBRT (40 Gy/5 fractions) underwent a CT-scan in treatment position before each of the first three fractions using the CT-on-rails system. OARs (stomach, duodenum, bowel) were manually delineated and concatenated to one structure (Gastro-Intestinal Organ, GIO). To overlay the planned dose distribution, fiducial-based alignment of the fraction CT with the planning CT was performed. Planned DVH parameters of the OAR were compared to the parameters calculated in the fractions CTs. RESULTS: Compared to the treatment plan, the median V35, D2, D5, D10 and Dmax of the fraction CTs in the GIO was increased by 1.0 (IQR: 0.2-2.6), 4.4% (0.4-10.8), 2.3% (0.2-7.5), 3.3% (-0.4 to 7.1), and 12.0% (5.0-18.9) respectively. Median increase was statistically significant for all parameters in GIO and for V35 in all critical structures at Wilcoxon test. CONCLUSIONS: Anatomical interfraction variations increase OAR dose during SBRT for pancreatic cancer daily imaging using integrated CT/CyberKnife may allow to implement strategies to reduce the risk of OAR overirradiation during pancreatic SBRT.
引用
- Loi M, Magallon-Baro A, Suker M, et al. Pancreatic cancer treated with SBRT: Effect of anatomical interfraction variations on dose to organs at risk. Radiother Oncol. 2019. PMID: 31005226. doi:10.1016/j.radonc.2019.01.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。